November 15, 2022 10:40 AM Eastern Standard Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced for its third quarter ended September 30, 2022 and that it has filed its quarterly report on Form 10-Q for…
August 23, 2022 11:00 AM Eastern Daylight Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc., (OTCPINK: FZMD), (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has been ranked number 149 on the 2022 list of Dallas-Fort Worth’s 150 largest public companies, by the Dallas…
Acromioclavicular Reconstruction System The novel M-Fix implant and J-Pass suture delivery device are designed to facilitate acromioclavicular reconstruction addressing coracoclavicular ligament reconstruction in acromioclavicular dislocations and fractures. Anatomic Recreates 3-D ligament structure Better Biomechanics Improved wear characteristics M-Fix construct closely approximates ligament stiffness Safer No drill holes = Lower fracture risk Easier J-Pass proprietary passer…
April 11, 2022 10:36 AM Eastern Daylight Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the appointment of new Chief Financial Officer and member of the Executive Board, Lawrence (“Larry”) S. Yellin. As CFO, Mr.…
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number:…
Natural Matrix Protein Through 30 years of innovation in BMP science, Induce NMP was developed to unlock the natural healing and regenerative capabilities of human bone. Designed to ensure high levels of BMPs and other bone growth factors are maintained, Induce NMP is a novel bioimplant with testing demonstrating significantly better bone quality and growth.…
Viable Bone Matrix An osteoconductive three-dimensional scaffold with cortical and cancellous components. A demineralized cortical bone scaffold (demineralized cortical bone has been identified to have osteoinductive potential). Viable endogenous bone cells to support osteogenic healing processes. Average cell viability exceeds 92% post-thaw. Average of 1.5 Million viable cells per cc of allograft. No rinsing or…
December 15, 2021 09:30 AM Eastern Standard Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the official distribution partnership with BRM Extremities S.r.l. (“BRM”) for the exclusive US national distribution of Silktoe® metatarsophalangeal joint arthroplasty…
Fuse Medical, Inc. Announces Third Quarter 2021 Financial Results November 11, 2021 09:00 AM Eastern Standard Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for…
Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix September 09, 2021 11:11 AM Eastern Daylight Time RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the official launch of the FuseChoice™ Dermal Matrix line (“FuseChoice™ Derm”). This…